Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer
Background/Aims: Androgen receptor (AR), a steroid hormone receptor, has recently emerged as prognostic and treatment-predictive marker in breast cancer. Previous studies have shown that AR is widely expressed in up to one-third of triple-negative breast cancer (TNBC). However, the role of AR in TNB...
Main Authors: | Aiyu Zhu, Yan Li, Wei Song, Yumei Xu, Fang Yang, Wenwen Zhang, Yongmei Yin, Xiaoxiang Guan |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-03-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/443052 |
Similar Items
-
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
by: Maša Brumec, et al.
Published: (2021-04-01) -
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
by: Dubrava AL, et al.
Published: (2023-05-01) -
Distinct p63 and p73 Protein Interactions Predict Specific Functions in mRNA Splicing and Polyploidy Control in Epithelia
by: Julian M. Rozenberg, et al.
Published: (2020-12-01) -
DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death
by: Katsuhiko Itoh, et al.
Published: (2019-09-01) -
A família do p53: aspectos estruturais e funcionais do p73 e do p63 The p53 family: structural and functional aspects of p73 and p63
by: Alfredo Ribeiro-Silva, et al.
Published: (2003-06-01)